首页|认知行为疗法对合并躯体疾病的老年抑郁症患者的疗效与优势

认知行为疗法对合并躯体疾病的老年抑郁症患者的疗效与优势

扫码查看
随着人口老龄化的加速,老年抑郁症(DEP)的发病率逐年增加,严重威胁着老年人的身心健康.老年患者是DEP的特殊群体,常合并躯体疾病.以合并躯体疾病的老年DEP患者为研究对象,评价认知行为疗法(CBT)联合低剂量度洛西汀的抗抑郁疗效和预后整体生活质量(QoL),指标包括基于汉密尔顿抑郁量表(HAMD)的临床起效时间、基于蒙哥马利抑郁评定量表(MADRS)的抗抑郁疗效、Croog QoL量表.结果显示,研究组治疗2周时的临床有效率(77.4%)显著高于药物对照组(60.8%)(P=0.027),研究组1 a时的抑郁程度低于对照组(P=0.005),研究组1、1.5 a时的QoL显著高于对照组(P<0.001)(P=0.035).说明CBT联合治疗合并躯体疾病的老年DEP具有缩短起效时间、提高抗抑郁疗效,改善患者整体功能,提高预后QoL的优势,可促进患者回归社会生活.
Efficacy and advantages of cognitive-behavioral therapy in elderly depression patients complicated with physical diseases
With the acceleration of population aging,the incidence of senile depression is increasing year by year,which seriously threatens the physical and mental health of the elder adults.As a special group of patients,the senile depression patients are often accompanied with physical diseases.This study evaluated the antidepressant efficacy and prognostic quality of life(QoL)of cognitive-behavioral therapy(CBT)combined with low-dose Duloxetine in elderly patients of depression with comorbidities.The indicators are the clinical onset time of the antidepressant based on the Hamilton Rating Scale for Depression(HAMD),the antidepressant efficacy based on the Montgomery-Asberg Depression Rating Scale(MADRS),and the Croog QoL.The results show that the clinical effective rate(77.4%)of the treatment group at 2 weeks was significantly higher than that of the control group(60.8%)(P=0.027).The depression level of the treatment group at 1 year was lower than that of the control group(P=0.005),and the QoL of the treatment group at 1 and 1.5 years was significantly higher than that of the control group(P<0.001)(P=0.035).It suggests that the CBT combined with antidepressant can shorten the onset time,improve its efficacy and the overall function and prognostic QoL of the patients,helping them to return to social activities.

senile depressionphysical diseasescognitive-behavioral therapyprognostic quality of lifeclinical efficacy timesselectiveserotonin-norepinephrine reuptake inhibitor

李平、孙志刚、徐曼华、何兰英、杜义敏、王立峰、张培、宋丽华

展开 >

石家庄市第八医院,石家庄 050081

石家庄市精神心理疾病临床医学研究中心,石家庄 050081

老年抑郁症 躯体疾病 认知行为疗法 预后生活质量 临床起效时间 5-羟色胺及去甲肾上腺素再摄取抑制剂

2024

科技导报
中国科学技术协会

科技导报

CSTPCD北大核心
影响因子:0.559
ISSN:1000-7857
年,卷(期):2024.42(22)